V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002364 | 210005932 | 1.67 | 49.8 | Adjuvant (A) | 2017-12-02 | 2017-12-23 | Docetaxel | 02 | N | DOCETAXEL | 100020222 |
| 210002365 | 210005933 | 1.65 | 74.4 | Adjuvant (A) | 2018-11-15 | 2018-11-30 | PACLITAXEL | null | N | PACLITAXEL | 100897481 |
| 210002368 | 210005934 | 1.63 | 72.45 | Adjuvant (A) | null | 2018-11-18 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100260920 |
| 210002369 | 210005935 | 1.66 | 89.3 | Neo-adjuvant (N) | 2018-11-29 | 2018-12-04 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101207021 |
| 210002370 | 210005936 | 1.65 | 97.8 | Palliative (P) | 2018-12-04 | 2019-05-21 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101351694 |
| 210002371 | 210005937 | null | 58.5 | Adjuvant (A) | 2018-12-29 | 2019-01-03 | Trastuzumab 21 day loading dose | null | N | TRASTUZUMAB | 100618231 |
| 210002372 | 210005938 | null | 94 | Palliative (P) | 2019-02-03 | 2019-02-17 | Trastuzumab | 02 | null | TRASTUZUMAB | 101701087 |
| 210002373 | 210005939 | null | 59.4 | null | 2018-11-21 | 2018-12-01 | PACLITAXEL | 02 | null | PACLITAXEL | 101830721 |
| 210002374 | 210005940 | 1.58 | null | Adjuvant (A) | 2018-03-24 | 2018-04-08 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100655188 |
| 210002375 | 210005941 | 1.69 | 54.2 | Adjuvant (A) | 2017-05-02 | 2017-05-09 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 100472584 |
| 210002378 | 210005942 | 1.71 | 75.5 | Adjuvant (A) | 2017-07-06 | 2017-09-16 | Docetaxel | 02 | N | DOCETAXEL | 101606560 |
| 210002379 | 210005943 | 1.6 | 98.8 | Adjuvant (A) | 2016-06-27 | 2016-09-27 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100101131 |
| 210002380 | 210005944 | 1.68 | 55.7 | Adjuvant (A) | 2017-01-13 | 2017-01-28 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100529435 |
| 210002381 | 210005945 | 1.59 | 65.6 | Adjuvant (A) | 2019-04-07 | 2019-04-22 | Trastuzumab Subcutaneous | N | N | TRASTUZUMAB | 101499226 |
| 210002384 | 210005946 | 1.58 | 67.4 | Adjuvant (A) | 2019-10-25 | 2019-11-12 | Docetaxel | 02 | N | DOCETAXEL | 100493145 |
| 210002385 | 210005947 | 1.7 | 53 | Adjuvant (A) | 2018-04-01 | 2018-04-02 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100278495 |
| 210002386 | 210005948 | 1.56 | 84.8 | Adjuvant (A) | 2019-03-13 | 2019-03-14 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101149357 |
| 210002388 | 210005950 | 1.74 | null | Adjuvant (A) | 2021-02-18 | 2021-02-25 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100959538 |
| 210002390 | 210005951 | null | null | null | 2019-01-09 | 2019-01-29 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100896205 |
| 210002391 | 210005952 | 1.64 | 61.6 | Palliative (P) | 2016-10-23 | 2016-11-07 | Paclitaxel 7 day | null | N | PACLITAXEL | 100021100 |
| 210002392 | 210005953 | null | 80.8 | null | 2019-03-02 | 2019-03-25 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100659269 |
| 210002394 | 210005954 | null | 83.6 | null | 2017-12-27 | 2017-12-28 | Trastuzumab Subcutaneous | N | null | TRASTUZUMAB | 100004131 |
| 210002395 | 210005955 | 1.64 | 81.6 | Palliative (P) | null | 2019-08-29 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100393824 |
| 210002399 | 210005958 | null | null | Palliative (P) | 2021-10-02 | 2021-10-04 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101369637 |
| 210002401 | 210005959 | 1.67 | 84.8 | Adjuvant (A) | null | 2018-05-26 | Trastuzumab 21 day loading dose | null | N | TRASTUZUMAB | 100234510 |
| 210002402 | 210005960 | 1.73 | 135.8 | Adjuvant (A) | 2019-06-20 | 2019-06-20 | Docetaxel | N | N | DOCETAXEL | 100907387 |
| 210002404 | 210005962 | null | 66 | null | null | 2018-08-16 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100013897 |
| 210002405 | 210005963 | 1.6 | 90.7 | Adjuvant (A) | 2017-01-18 | 2017-02-09 | Docetaxel | 02 | N | DOCETAXEL | 100157767 |
| 210002406 | 210005964 | 1.62 | 55.5 | Adjuvant (A) | 2016-04-03 | 2016-04-10 | PACLITAXEL | null | N | PACLITAXEL | 101482356 |
| 210002407 | 210005965 | null | null | null | 2018-12-29 | 2019-01-01 | Trastuzumab | null | null | TRASTUZUMAB | 101709008 |
| 210002409 | 210005966 | 1.74 | 62.8 | Adjuvant (A) | 2017-01-16 | 2017-01-22 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100336771 |
| 210002410 | 210005967 | 1.63 | 53.5 | Palliative (P) | 2018-05-27 | 2018-06-05 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101161579 |
| 210002413 | 210005968 | 1.61 | 79.8 | Adjuvant (A) | 2016-03-02 | 2016-05-26 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101324725 |
| 210002416 | 210005969 | 1.6 | 59 | null | 2017-10-11 | 2018-08-30 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101057912 |
| 210002417 | 210005970 | 1.65 | null | Neo-adjuvant (N) | null | 2018-08-24 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100707453 |
| 210002418 | 210005971 | 1.57 | 54.1 | Neo-adjuvant (N) | null | 2019-01-26 | PACLITAXEL | 02 | N | PACLITAXEL | 101805602 |
| 210002420 | 210005973 | 1.59 | 78.1 | Adjuvant (A) | 2016-03-06 | 2016-12-10 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 101655033 |
| 210002422 | 210005975 | 1.74 | 57 | Adjuvant (A) | null | 2019-05-10 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101383144 |
| 210002425 | 210005977 | 1.65 | 72.1 | Neo-adjuvant (N) | 2017-03-03 | 2018-05-03 | Paclitaxel 7 day | null | N | PACLITAXEL | 101721656 |
| 210002426 | 210005978 | null | null | null | null | 2018-02-27 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101417041 |
| 210002427 | 210005979 | 1.52 | 86.1 | Adjuvant (A) | 2018-05-04 | 2018-05-25 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101531006 |
| 210002428 | 210005980 | 1.58 | null | Adjuvant (A) | 2019-07-10 | 2019-07-27 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101140143 |
| 210002431 | 210005982 | 1.68 | 58.2 | Adjuvant (A) | 2019-03-19 | 2019-04-30 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100024558 |
| 210002432 | 210005983 | 1.61 | 93.5 | Adjuvant (A) | null | 2019-09-22 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101549675 |
| 210002433 | 210005984 | 1.58 | 71.4 | Adjuvant (A) | null | 2017-08-05 | Docetaxel | 02 | N | DOCETAXEL | 100096208 |
| 210002434 | 210005985 | null | 69.8 | null | 2016-12-15 | 2017-01-07 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100377031 |
| 210002435 | 210005986 | 1.69 | 47.5 | Adjuvant (A) | 2019-04-04 | 2019-07-20 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100387725 |
| 210002438 | 210005987 | null | 103 | null | 2018-10-08 | 2018-10-18 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101764048 |
| 210002441 | 210005988 | 1.72 | 82.3 | Adjuvant (A) | 2017-01-30 | 2017-03-01 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100246549 |
| 210002442 | 210005989 | 1.58 | 82.9 | null | 2017-09-07 | 2017-09-10 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100747650 |